Checkmate Pharmaceuticals, Inc.: common_shares_outstanding
| Value | {"unit": "shares", "value": 21625891, "concept": "us-gaap:CommonStockSharesOutstanding"} |
|---|---|
| Period | (as of 2021-06-30) |
| Status | current |
| Entity | Checkmate Pharmaceuticals, Inc. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T17:00:28.648796+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/4f5ebc3a-5de3-45fb-855d-8e48893dc04e
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001193125-21-244686 · Open the official SEC filing →Retrieved: 2026-08-19T17:00:28.648796+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001651431/common-shares-outstanding/2021-06-30 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/4f5ebc3a-5de3-45fb-855d-8e48893dc04e
History
- no predecessors — first report